TherapeuticsMD (TXMD) Debt Ratio (2010 - 2022)

TherapeuticsMD's Debt Ratio history runs 9 years deep, the most recent figure standing at 0.7 for Q3 2022.

• Quarterly Debt Ratio fell 21.53% year-over-year to 0.7 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 0.7 (down 21.53% YoY) and the FY2021 annual result came in at 1.11, down 15.12% from the prior year.
• Debt Ratio was 0.7 for Q3 2022 at TherapeuticsMD, up from 0.62 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.52 in Q1 2022 and bottomed at 0.31 in Q3 2018.
• A 5-year average of 0.84 and a median of 0.79 in 2019 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2019 — Debt Ratio soared 151.28% — and 2021, when it plunged 33.38%.
• TherapeuticsMD's Debt Ratio stood at 0.35 in 2018, then jumped by 111.39% to 0.73 in 2019, then surged by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then slumped by 37.08% to 0.7 in 2022.
• Business Quant data shows TXMD's Debt Ratio at 0.7 in Q3 2022, 0.62 in Q2 2022, and 1.52 in Q1 2022.